loading

Revelation Biosciences Inc Borsa (REVB) Ultime notizie

Post-Trade Analysis: Revelation Biosciences Inc (REVB) Slides -1.79, Closing at 1.65 – DWinneX - The Dwinnex

pulisher
The Dwinnex

Bears are Losing Control Over Revelation Biosciences, Inc. (REVB), Here's Why It's a 'Buy' Now - Yahoo Movies Canada

pulisher
Yahoo Movies Canada

Bears are Losing Control Over Revelation Biosciences, Inc. (REVB), Here's Why It's a 'Buy' Now - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Rhinitis Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by ... - openPR

pulisher
openPR

Rhinitis Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by ... - openPR

pulisher
openPR

Rhinitis Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by ... - Barchart

pulisher
Barchart

Revelation Biosciences, Inc. (NASDAQ:REVB) to Post Q2 2024 Earnings of ($1.34) Per Share, Roth Capital Forecasts - Defense World

pulisher
Defense World

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 - businesswire.com

pulisher
businesswire.com

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024 - Yahoo Finance

pulisher
Yahoo Finance

Bears are Losing Control Over Revelation Biosciences, Inc. (REVB), Here's Why It's a 'Buy' Now - Yahoo New Zealand News

pulisher
Yahoo New Zealand News

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023 - Business Wire

pulisher
Business Wire

Revelation Biosciences Showcases Research at Nephrology Conference - TipRanks.com - TipRanks

pulisher
TipRanks

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference - Business Wire

pulisher
Business Wire

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini - Business Wire

pulisher
Business Wire

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on ... - Business Wire

pulisher
Business Wire

Thinking about buying stock in Meta Platforms, Ocular Therapeutix, Phathom Pharmaceuticals, Revelation Biosciences ... - PR Newswire

pulisher
PR Newswire

Top 5 Health Care Stocks That Are Preparing To Pump In February

pulisher
Benzinga

Revelation Biosciences Secures $6.2M in Public Offering - TipRanks.com - TipRanks

pulisher
TipRanks

Top 5 Health Care Stocks That Are Preparing To Pump In February - Markets Insider

pulisher
Markets Insider

Healthcare Stocks on the Move Tuesday: EQ, TENX, IMNM, KPTI, BRTX, AHG, REVB, IMMX - InvestorsObserver

pulisher
InvestorsObserver

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering - Business Wire

pulisher
Business Wire

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider

pulisher
Markets Insider

Dow Jumps 250 Points; Honeywell Issues Weak Forecast

pulisher
Benzinga

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Best Undervalued Stocks for May 2024 - Investopedia

pulisher
Investopedia

Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations

pulisher
Benzinga

Nasdaq Surges 100 Points; US Jobless Claims Increase To 224,000

pulisher
Benzinga

Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why Is Revelation Biosciences (REVB) Stock Down 62% Today? - InvestorPlace

pulisher
InvestorPlace

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why Sintx Technologies Shares Are Trading Higher By Over 39%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Revelation Biosciences Shares Corporate Presentation Update - TipRanks

pulisher
TipRanks

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

pulisher
InvestorPlace

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Healthcare Stocks on the Move Tuesday: NEXI, PEPG, VVOS, ACON, NYXH, REVB, ALRN, AVRO - InvestorsObserver

pulisher
InvestorsObserver

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal

pulisher
Benzinga

Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today? - InvestorPlace

pulisher
InvestorPlace

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

pulisher
Benzinga

Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session By ... - Investing.com UK

pulisher
Investing.com UK

Crude Oil Down 1%; Lockheed Martin Earnings Top Views

pulisher
Benzinga

Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings

pulisher
Benzinga

Dow Tumbles 150 Points; Procter & Gamble Shares Rise On Upbeat Earnings - Ensysce Biosciences (NASDAQ:ENS - Benzinga

pulisher
Benzinga

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors - Yahoo Finance

pulisher
Yahoo Finance

Vedanta Biosciences Raises $106.5M in Funding - FinSMEs

pulisher
FinSMEs
$75.07
price up icon 0.79%
$148.85
price down icon 3.50%
$28.20
price up icon 0.75%
$148.43
price down icon 1.07%
$371.02
price up icon 2.45%
$100.60
price up icon 1.87%
Capitalizzazione:     |  Volume (24 ore):